Edition:
United States

People: Agenus Inc (AGEN.O)

AGEN.O on Consolidated Issue listed on NASDAQ Capital Market

4.84USD
26 Jul 2016
Change (% chg)

$0.10 (+2.11%)
Prev Close
$4.74
Open
$4.72
Day's High
$4.89
Day's Low
$4.67
Volume
781,521
Avg. Vol
1,043,678
52-wk High
$8.69
52-wk Low
$2.61

Armen, Garo 

Dr. Garo H. Armen, Ph.D., is a founder and serves as Chairman of the Board, Chief Executive Officer of Agenus Inc. Dr. Armen brings to our Board a deep historical and practical knowledge of the business of the Company and its technologies, as well as years of expertise in the financial and biopharmaceutical arenas. From mid-2002 through 2004, he was Chairman of the Board of Directors for the biopharmaceutical company Elan Corporation, plc which he helped restructure. Dr. Armen currently serves as non-executive Chairman of the Board of Directors of Protagenic Therapeutics, Inc., a privately held biotechnology company. Dr. Armen is also the founder and Chairman of the Children of Armenia Fund, a philanthropic organization established in 2000 that is dedicated to the positive development of the children and youth of rural Armenia. He holds a Ph.D. degree in physical organic chemistry from the City University of New York.

Basic Compensation

Total Annual Compensation, USD 922,360
Restricted Stock Awards, USD --
Long-Term Incentive Plans, USD --
All Other, USD 1,361,170
Fiscal Year Total, USD 2,283,530

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --
Name Fiscal Year Total

Garo Armen

2,283,530

C. Evan Ballantyne

--

Robert Stein

1,572,510

Christine Klaskin

601,228

Karen Valentine

864,071

Ozer Baysal

593,602
As Of  30 Dec 2014